Title:
SUBSTITUTED SULFONAMIDE COMPOUND AND ITS METHOD OF APPLICATION AS MEDICINE FOR TREATMENT OF CNS DISORDER, OBESITY, AND DIABETES MELLITUS TYPE 2
Document Type and Number:
Japanese Patent JP2010013473
Kind Code:
A
Abstract:
To provide a medicine having 5-HT6 receptor antagonist activity and useful for prevention and treatment of obesity, diabetes mellitus type 2 and/or central nervous system disorder.
The substituted sulfonamide compound is represented by general formula (I) (wherein P is a sulfonamide or amide-substituted sulfonic acid, provided that P and R3 are mutually allocated at meta- or para-position; R3 is piperazine, 1,4-diazepan, etc.; ring A-B is naphthalene, isoquinoline, quinoline, 1,7-naphthyridine, benzofuran, etc.).
Inventors:
BEIERLEIN KATARINA
BREMBERG ULF
CALDIROLA PATRIZIA
JENMALM JENSEN ANNIKA
JOHANSSON GARY
MOTT ANDREW
TEDENBORG LARS
THOR MARKUS
BREMBERG ULF
CALDIROLA PATRIZIA
JENMALM JENSEN ANNIKA
JOHANSSON GARY
MOTT ANDREW
TEDENBORG LARS
THOR MARKUS
Application Number:
JP2009209444A
Publication Date:
January 21, 2010
Filing Date:
September 10, 2009
Export Citation:
Assignee:
BIOVITRUM AB PUBL
International Classes:
C07D211/70; A61K31/407; A61K31/437; A61K31/4409; A61K31/4418; A61K31/495; A61K31/496; A61K31/4965; A61K31/551; A61P3/04; A61P3/10; A61P25/00; A61P25/06; A61P25/14; A61P25/16; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P25/30; A61P43/00; C07D215/40; C07D215/58; C07D217/22; C07D231/16; C07D241/04; C07D243/08; C07D295/096; C07D295/12; C07D295/135; C07D307/79; C07D319/18; C07D333/34; C07D333/62; C07D409/12; C07D413/12; C07D471/04; C07D487/04; C07D487/08; A61K; C07C; C07D
Attorney, Agent or Firm:
Mitsuo Tanaka
Hiroshi Yamazaki
Tadayuki Motoyama
Kenji Tomita
Hiroshi Yamazaki
Tadayuki Motoyama
Kenji Tomita